Ozempic and Your Brain — What the Science Says

Ozempic and Your Brain — What the Science Says - Craving Control: Rewiring Reward Circuits

20 min · 7 apr 2026
aflevering Ozempic and Your Brain — What the Science Says - Craving Control: Rewiring Reward Circuits artwork

Beschrijving

Ben Synth explores emerging research on how Ozempic and GLP-1 drugs may rewire the brain's reward circuits, potentially reducing cravings for nicotine, alcohol, and opioids. The episode covers observational studies, ongoing investigations, and the neuroscience of desire—examining what happens when a diabetes medication appears to alter human wanting itself. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Ozempic and Your Brain — What the Science Says community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

4 afleveringen

aflevering Ozempic and Your Brain — Uncover what the science really says with Dr. Ben Synth artwork

Ozempic and Your Brain — Uncover what the science really says with Dr. Ben Synth

Join Dr. Ben Synth as he cuts through the hype to explore the neuroscience behind Ozempic and GLP-1 drugs—far beyond weight loss. Discover how these medications may rewire brain circuits tied to addiction, potentially protect against Alzheimer's, and transform emotional responses in ways researchers are only beginning to understand. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 202644 s
aflevering Ozempic and Your Brain — What the Science Says - Craving Control: Rewiring Reward Circuits artwork

Ozempic and Your Brain — What the Science Says - Craving Control: Rewiring Reward Circuits

Ben Synth explores emerging research on how Ozempic and GLP-1 drugs may rewire the brain's reward circuits, potentially reducing cravings for nicotine, alcohol, and opioids. The episode covers observational studies, ongoing investigations, and the neuroscience of desire—examining what happens when a diabetes medication appears to alter human wanting itself. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 202620 min
aflevering Ozempic and Your Brain — What the Science Says - Semaglutide's Impact on Depression artwork

Ozempic and Your Brain — What the Science Says - Semaglutide's Impact on Depression

Ben Synth explores how Ozempic affects mood and cognition through serotonin and dopamine systems. While large studies show psychiatric safety, individual responses vary dramatically. Research reveals promising links between gut health, brain inflammation, and mental wellness—suggesting weight-loss drugs may revolutionize how we understand depression treatment. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 202622 min
aflevering Ozempic and Your Brain — What the Science Says - The Alzheimer's Question artwork

Ozempic and Your Brain — What the Science Says - The Alzheimer's Question

Join AI host Ben Synth as he examines research suggesting semaglutide (Ozempic) may reduce Alzheimer's risk by up to 33%. Drawing from studies of over 100 million patient records, Ben explores four mechanisms—neuroinflammation reduction, improved vascular function, amyloid plaque control, and enhanced neuroplasticity—while carefully distinguishing promising observational data from proven causation. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 apr 202623 min